Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Plunkett's Biotech Research & Development Trends & Statistics Overview 2007 (Summary)

Published by: Plunkett Research, Ltd.

Published: Jan. 8, 2007 - 35 Pages


Table of Contents



Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms

From India to Singapore to China, Nations Compete Fiercely in Biotech Development

New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow

New Drug Delivery Systems

Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race

Stem Cells—Therapeutic Cloning Techniques Advance

Stem Cells—A New Era of Regenerative Medicine Looms

Agricultural Biotechnology Scores Breakthroughs but Causes Controversy

Industry Statistics Overview

A Closer Look at the Drug Discovery and Development Process

Annual Percent Change in U.S. Research & Development Spending by Research-Based Pharmaceutical Companies, 1980-2005

Domestic R&D Spending as a Percentage of Domestic Sales, U.S. Research-Based Pharmaceutical Companies: Selected Years 1970-2005

Global R&D Investments by Research-Based Pharmaceutical Companies: 1970-2005

R&D Spending By Function, U.S. Research-based Pharmaceutical Companies: 2004

U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME*) Approvals, 1993-2005

Profiles on the Top 10 Biotech R&D Companies by Number of Employees

Abstract

This summary contains selected trends and statistics chapters excerpted from Plunkett's Biotech & Genetics Industry Almanac 2007- a market research guide to the biotech & genetics industry - that focus on the research & development activities in the biotechnology industry. It includes our analysis of the major trends such as Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms, and New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow. In addition, we provide statistical tables such as Domestic R&D Spending as a Percentage of Domestic Sales, U.S. Research-Based Pharmaceutical Companies: Selected Years 1970-2005 and U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME*) Approvals, 1993-2005.

As a finishing touch, individual company profiles are provided for ten of the leading biotech research & development companies in the world. Wield this tool for strategic planning, business development, or industry analysis.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009